Mechanisms of podocyte injury and implications for diabetic nephropathy

F Barutta, S Bellini, G Gruden - Clinical Science, 2022 - portlandpress.com
Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies,
including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and …

Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation

LJH Rasmussen, JEV Petersen… - Frontiers in …, 2021 - frontiersin.org
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation
that plays a major role in immunosenescence and in development and progression of many …

Cellular and molecular mechanisms of kidney fibrosis

S Djudjaj, P Boor - Molecular aspects of medicine, 2019 - Elsevier
Renal fibrosis is the final pathological process common to any ongoing, chronic kidney
injury or maladaptive repair. It is considered as the underlying pathological process of …

The evolving story of apolipoprotein L1 nephropathy: the end of the beginning

P Daneshpajouhnejad, JB Kopp, CA Winkler… - Nature Reviews …, 2022 - nature.com
Genetic coding variants in APOL1, which encodes apolipoprotein L1 (APOL1), were
identified in 2010 and are relatively common among individuals of sub-Saharan African …

Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach

AS De Vriese, S Sethi, KA Nath… - Journal of the …, 2018 - journals.lww.com
FSGS describes a renal histologic lesion with diverse causes and pathogenicities that are
linked by podocyte injury and depletion. Subclasses of FSGS include primary, genetic, and …

The key role of NLRP3 and STING in APOL1-associated podocytopathy

J Wu, A Raman, NJ Coffey, X Sheng, J Wahba… - The Journal of clinical …, 2021 - jci.org
Coding variants in apolipoprotein L1 (APOL1), termed G1 and G2, can explain most excess
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

G Hindy, DJ Tyrrell, A Vasbinder, C Wei… - The Journal of clinical …, 2022 - jci.org
People with kidney disease are disproportionately affected by atherosclerosis for unclear
reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived …

Soluble urokinase receptor and acute kidney injury

SS Hayek, DE Leaf, A Samman Tahhan… - … England Journal of …, 2020 - Mass Medical Soc
Background Acute kidney injury is common, with a major effect on morbidity and health care
utilization. Soluble urokinase plasminogen activator receptor (suPAR) is a signaling …

Soluble urokinase receptor (SuPAR) in COVID-19–related AKI

TU Azam, HR Shadid, P Blakely… - Journal of the …, 2020 - journals.lww.com
Background AKI commonly occurs in patients with coronavirus disease 2019 (COVID-19). Its
pathogenesis is poorly understood. The urokinase receptor system is a key regulator of the …

APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease

S Datta, BM Antonio, NH Zahler, JW Theile… - The Journal of clinical …, 2024 - jci.org
Two coding variants of apolipoprotein L1 (APOL1), called G1 and G2, explain much of the
excess risk of kidney disease in African Americans. While various cytotoxic phenotypes have …